Literature DB >> 19145416

[Adrenalectomy for preservation of adrenocortical function. Indication and results].

M K Walz1.   

Abstract

The standard procedure for adrenal tumors is total adrenalectomy. In order to preserve adrenocortical function, partial adrenalectomy has become an accepted and proven option in bilateral hereditary pheochromocytomas. For this at least one third of one gland has to be maintained. In unilateral adrenal tumors, partial adrenalectomy has mainly been used in Conn's syndrome. Studies demonstrate results identical to those of total adrenalectomy. All other adrenal tumors are exceptional indications for partial adrenalectomy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19145416     DOI: 10.1007/s00104-008-1612-9

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  74 in total

1.  Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa.

Authors:  E Edström; S Gröndal; F Norström; M Palmér; K A Svensson; H Widell; B Hamberger
Journal:  Eur J Surg       Date:  1999-05

2.  Pheochromocytoma--death of an axiom.

Authors:  Robert G Dluhy
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

3.  Partial laparoscopic adrenalectomy for aldosterone-producing adenoma: short-and long-term results.

Authors:  S Al-Sobhi; R Peschel; G Bartsch; R Gasser; G Finkenstedt; G Janetschek
Journal:  J Endourol       Date:  2000-08       Impact factor: 2.942

4.  Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma.

Authors:  Birke Bausch; Wiktor Borozdin; Hartmut P H Neumann
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

5.  Unilateral laparoscopic adrenalectomy followed by contralateral retroperitoneoscopic partial adrenalectomy in a patient with multiple endocrine neoplasia type 2a syndrome.

Authors:  S Mugiya; K Suzuki; K Saisu; K Fujita
Journal:  J Endourol       Date:  1999-03       Impact factor: 2.942

6.  Long-term results of treatment of Cushing's disease by adrenalectomy.

Authors:  P Grabner; M Hauer-Jensen; J Jervell; A Flatmark
Journal:  Eur J Surg       Date:  1991-08

7.  Posterior retroperitoneoscopic partial adrenalectomy: clinical experience in 47 procedures.

Authors:  Isoji Sasagawa; Yasuhiro Suzuki; Keiichi Itoh; Takuji Izumi; Michiharu Miura; Hitoshi Suzuki; Yoshihiko Tomita
Journal:  Eur Urol       Date:  2003-04       Impact factor: 20.096

8.  [Retroperitoneal laparoscopic management of primary aldosteronism with report of 130 cases].

Authors:  Xu Zhang; Hua He; Zhong Chen; Shao-gang Wang; Hong-zhao Li; Xin Ma; Long-cheng Li; Zhang-qun Ye
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2004-09-22

9.  Retroperitoneoscopic partial adrenalectomy using an endoscopic stapling device in patients with adrenal tumor.

Authors:  I Sasagawa; H Suzuki; T Tateno; T Izumi; N Shoji; T Nakada
Journal:  Urol Int       Date:  1998       Impact factor: 2.089

10.  Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).

Authors:  J A van Heerden; C F Roland; J A Carney; S G Sheps; C S Grant
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more
  4 in total

1.  Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Beate Meier; Kurt W Schmid; Hartmut P H Neumann; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

2.  Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Authors:  Raouf Seyam; Mahmoud I Khalil; Mohamed H Kamel; Waleed M Altaweel; Rodney Davis; Nabil K Bissada
Journal:  Int Urol Nephrol       Date:  2019-01-08       Impact factor: 2.370

Review 3.  Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.

Authors:  Judith Favier; Laurence Amar; Anne-Paule Gimenez-Roqueplo
Journal:  Nat Rev Endocrinol       Date:  2014-11-11       Impact factor: 43.330

Review 4.  [Function-preserving adrenalectomy for adrenal tumors].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.